Audicus Omni 2 vs Lexie B3

The Audicus Omni 2 is a premium-priced behind-the-ear OTC hearing aid available for $1,898. With a SoundScore of 4.6/5 and an A grade, it ranks #5 among 65 OTC hearing aids tested, placing it in the top 6% of its category. In our lab testing, the Omni 2 demonstrates strong speech clarity in quiet environments, scoring 4.2/5—well above the category average by 1.38 points. Speech in noise performance is more modest at 2.3/5, which is above the category average by 0.79 points but mixed in absolute terms. This pattern suggests the device handles everyday conversations well while challenging listening situations may still present difficulty. Music streaming is a particular strength, scoring 3.6/5 and exceeding the category average by a substantial 1.68 points. Feedback handling is excellent at 4.5/5, virtually matching the category average. Own-voice comfort scores a solid 3.0/5, which is 0.49 points above average for OTC devices. The Omni 2 offers both rechargeable and disposable battery options, along with streaming compatibility for iPhone and Android devices with hands-free capability. It has earned Expert's Choice Awards for both 2023 and 2024. Consumers seeking alternatives in this price range may also consider the similarly-priced Lucid Tala, while the lower-priced Lexie B3 offers competitive performance for those with tighter budgets.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.